DefinitionThis section has been translated automatically.
Exenatide (Byetta®) short-acting (2x daily)
Exenatide (Bydureon®) long-acting (once a week)
GLP-1 receptor agonist of the first generation for the treatment of inadequately controlled type 2 DM in combination with dietary changes and more exercise, possibly in addition to metformin or other antidiabetic medication.
